Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability
Jessica R. Bobbitt(Cleveland Clinic Lerner College of Medicine), Ruth A. Keri(Cleveland Clinic Lerner College of Medicine)
Cited by 0
Related Papers
Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
|Breast Cancer Research|2017|50
Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction
|Journal of Biological Chemistry|2023|7